Auteurs Gual P, Giordano S, Williams TA, Rocchi S, Van Obberghen E, Comoglio PM
Oncogene Mar 2000
Different point mutations in the met oncogene elicit distinct biological properties.Auteurs Giordano S, Maffe A, Williams TA, Artigiani S, Gual P, Bardelli A, Basilico C, Michieli P, Comoglio PM
FASEB journal : official publication of the Federation of American Societies for Experimental Biology Feb 2000
Potential involvement of FRS2 in insulin signaling.Auteurs Delahaye L, Rocchi S, Van Obberghen E
Endocrinology Jan 2000
MET(PRC) mutations in the Ron receptor result in upregulation of tyrosine kinase activity and acquisition of oncogenic potential.Auteurs Williams TA, Longati P, Pugliese L, Gual P, Bardelli A, Michieli P
Journal of cellular physiology Dec 1999
Peroxisome proliferator-activated receptor-gamma: a versatile metabolic regulator.Auteurs Rocchi S, Auwerx J
Annals of medicine Nov 1999
Interaction of Janus kinases JAK-1 and JAK-2 with the insulin receptor and the insulin-like growth factor-1 receptor.Auteurs Gual P, Baron V, Lequoy V, Van Obberghen E
Endocrinology Mar 1998
Transient uptake and storage of serotonin in developing thalamic neurons.Auteurs Lebrand C, Cases O, Adelbrecht C, Doye A, Alvarez C, El Mestikawy S, Seif I, Gaspar P
Neuron Nov 1996
Role of the insulin receptor C-terminal acidic domain in the modulation of the receptor kinase by polybasic effectors.Auteurs Baron V, Gual P, Alengrin F, Van Obberghen E
European journal of biochemistry Oct 1996
Insulin receptor-induced phosphorylation of cellular and synthetic substrates is regulated by the receptor beta-subunit C-terminus.Auteurs Gual P, Baron V, Alengrin F, Mothe I, Van Obberghen E
Endocrinology Aug 1996
A conformational change in the beta-subunit of the insulin-like growth factor I receptor identified by antipeptide antibodies.Auteurs Gual P, Baron V, Alengrin F, Van Obberghen E
Endocrinology Dec 1995